Recently, by collecting protein mass spectrometry data from 74 stage I lung adenocarcinoma (LUAD) patients from Taiwan, Lu and colleagues 13 revealed five prognostic biomarkers, ADAM10, MAOA, MIF, TEK, and THBS2. This evidence concerns the gene ADAM10 and lung adenocarcinoma.